Meet the Class of 2027

Three people giving the Hook 'em Horns hand gesture and holding a "Future Pharm.D." banner.
January 16, 2024
Get to know some of Texas Pharmacy's P1 students. We caught up with P1 Pharm.D. students Thomas, Seun, Marissa, Kayla, Kimberly, Paul and Princy to see how first year is going one semester in, what makes them excited about Texas Pharmacy and becoming a future Longhorn pharmacist and how they unwind after a long day of classes and studying.

FDA Considers Making Narcan Opioid Overdose Antidote Available Without Prescription

Two hands cradling a nasal spray dispenser for naloxone.
February 15, 2023
Clinical Associate Professor in the Division of Pharmacotherapy Dr. Kirk Evoy spoke to CNN about the possibilities of making naloxone, a medication used to reverse or reduce the effects of opioids, available over-the-counter.

Student Pharmacists Earn AAPP Foundation Grants

American Association of Psychiatric Pharmacists (AAPP) Collegiate Chapter.
February 9, 2023
Four Texas Pharmacy Pharm.D. students have earned recent grants and recognition by the American Association of Psychiatric Pharmacists (AAPP) Foundation.

Meet the Class of 2026

A group of pharmacy students pose together during the Class of 2026 Block party celebration.
November 16, 2022
Get to know some of Texas Pharmacy's P1 students.

Pharmacists: The Most Accessible Healthcare Provider, Unless You Have a Substance Use Disorder

White pill bottle with white pills on a black background.
August 23, 2022
P4 students, Megan Yeung, Kami Johnston and Morgan Murchison co-author a peer-reviewed blog in Pulses encouraging educators to adapt to reflect the specific needs of people who use drugs and patients with substance use disorders. This blog also highlights UT Pharmacy as a U.S. leader in substance use disorder and harm reduction education for Pharm.D. students.

Fewer Than Half of U.S. Pharmacies Carry One of the Most Effective Drugs for Opioid Abuse

A pharmacist holding a box of medication.
June 13, 2022
Tara Law from Time writes about how few pharmacies carry buprenorphine, a life-saving drug to help treat opioid use disorder (OUD). Lucas Hill, Pharm.D., BCACP, director of the college's Pharmacy Addictions Research & Medicine (PhARM) program, offers his insight on the issue, and how the DEA's crackdown of the drug puts OUD patients at risk.

Pharmacy Students Report Both Motivators, Barriers to Attending Class Pre-, Post-Pandemic

Pie charts.
December 7, 2021
Student pharmacist Cara Rutledge (Pharm.D. Class of 2022) wrote an article for the Pharmacy Times about her honors program thesis which aimed to address the various complexities of student motivation, engagement and attendance in relation to mastery of course material.

UT Pharmacy Students Reflect on the Pandemic, Look to the Future

A person typing on a laptop in their house.
December 1, 2021
UT student pharmacists Kailee Marikar, Sadaf Helforoosh, Hannah McCullough, Agaustin Wong and Cara Rutledge talked to the Pharmacy Times’ Skylar Kenney about their experiences balancing their studies in the midst of the pandemic and how COVID-19 showed a pharmacist's vital role in public health.

Opioid Use Disorder Paper Earns ACCP Award

A box of naloxone vials.
October 8, 2021
A paper from UT College of Pharmacy researchers was awarded the 2021 Outstanding Paper of the Year from the American College of Clinical Pharmacy (ACCP) Ambulatory Care Practice Research Network. The paper investigates the availability of buprenorphine and naloxone in Texas to treat opioid use disorder.

Immunologic Resilience: A New Metric to Accurately Gauge COVID-19’s Path

The COVID-19 virus.
September 8, 2021
UT Pharmacy and UT Health Science Center San Antonio Assistant Professor Grace C. Lee, Pharm.D., Ph.D. is the first author of a recently published study that unveiled a novel concept, “immunologic resilience,” to accurately predict which COVID-19 patients will advance to severe disease and which will not.